- Home
- GMM vs IPSC Comparison
GMM vs IPSC Comparison
Compare GMM & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- IPSC
- Stock Information
- Founded
- GMM 2017
- IPSC 2019
- Country
- GMM China
- IPSC United States
- Employees
- GMM N/A
- IPSC N/A
- Industry
- GMM
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- GMM
- IPSC Health Care
- Exchange
- GMM Nasdaq
- IPSC Nasdaq
- Market Cap
- GMM 70.8M
- IPSC 58.1M
- IPO Year
- GMM 2023
- IPSC 2021
- Fundamental
- Price
- GMM $3.17
- IPSC $0.46
- Analyst Decision
- GMM
- IPSC Strong Buy
- Analyst Count
- GMM 0
- IPSC 5
- Target Price
- GMM N/A
- IPSC $3.67
- AVG Volume (30 Days)
- GMM 33.3K
- IPSC 481.8K
- Earning Date
- GMM 05-16-2025
- IPSC 05-08-2025
- Dividend Yield
- GMM N/A
- IPSC N/A
- EPS Growth
- GMM 62.17
- IPSC N/A
- EPS
- GMM 6.37
- IPSC N/A
- Revenue
- GMM $41,360,953.00
- IPSC $6,589,000.00
- Revenue This Year
- GMM N/A
- IPSC $1,064.82
- Revenue Next Year
- GMM N/A
- IPSC N/A
- P/E Ratio
- GMM $0.54
- IPSC N/A
- Revenue Growth
- GMM 53.82
- IPSC 194.81
- 52 Week Low
- GMM $0.21
- IPSC $0.42
- 52 Week High
- GMM $4.97
- IPSC $4.43
- Technical
- Relative Strength Index (RSI)
- GMM 35.19
- IPSC 27.79
- Support Level
- GMM $3.02
- IPSC $0.45
- Resistance Level
- GMM $3.49
- IPSC $0.59
- Average True Range (ATR)
- GMM 0.43
- IPSC 0.04
- MACD
- GMM -0.09
- IPSC -0.00
- Stochastic Oscillator
- GMM 9.71
- IPSC 16.67
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.